Treatment with heavy charged particles: Systematic review of clinical data and current clinical (comparative) trials

References

• Combs SE, Ellerbrock M, Haberer T, Habermehl D, Hoess A, Jakel O, et al. Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol 2010;49:1132–40.
   PubMed Web of Science ®Google Scholar
• Combs SE, Bohl J, Elsasser T, Weber KJ, Schulz-Ertner D, Debus J, et al. Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines. Int J Radiat Biol 2009;85:126–37.
   PubMed Web of Science ®Google Scholar
• Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jakel O, et al. Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys 2011; 81:e793–801.
   Google Scholar
• Tsujii H, Kamada T. A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol 2012;42: 670–85.
   PubMed Web of Science ®Google Scholar
• Tsujii H, Mizoe JE, Kamada T, Baba M, Kato S, Kato H, et al. Overview of clinical experiences on carbon ion radiotherapy at NIRS. Radiother Oncol 2004;73(Suppl 2): S41–9.
   Google Scholar
• Combs SE, Zipp L, Rieken S, Habermehl D, Brons S, Winter M, et al. In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells. Radiat Oncol 2012;7:9.
   PubMed Web of Science ®Google Scholar
• Fujita M, Otsuka Y, Imadome K, Endo S, Yamada S, Imai T. Carbon-ion radiation enhances migration ability and invasiveness of the pancreatic cancer cell, PANC-1, in vitro. Cancer Sci 2012;103:677–83.
   PubMed Web of Science ®Google Scholar
• Higo M, Uzawa K, Kawata T, Kato Y, Kouzu Y, Yamamoto N, et al. Enhancement of SPHK1 in vitro by carbon ion irradiation in oral squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2006;65:867–75.
   PubMed Web of Science ®Google Scholar
• Rieken S, Habermehl D, Wuerth L, Brons S, Mohr A, Lindel K, et al. Carbon ion irradiation inhibits glioma cell migration through downregulation of integrin expression. Int J Radiat Oncol Biol Phys 2012;83:394–9.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Fukawa T, Hirayama R, Yoshida Y, Musha A, Furusawa Y, et al. In vitro interaction of high-LET heavy-ion irradiation and chemotherapeutic agents in two cell lines with different radiosensitivities and different p53 status. Anticancer Res 2010;30:1961–7.
   PubMed Web of Science ®Google Scholar
• Becker D, Elsasser T, Tonn T, Seifried E, Durante M, Ritter S, et al. Response of human hematopoietic stem and progenitor cells to energetic carbon ions. Int J Radiat Biol 2009;85:1051–9.
   PubMed Web of Science ®Google Scholar
• Oonishi K, Cui X, Hirakawa H, Fujimori A, Kamijo T, Yamada S, et al. Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells. Radiother Oncol 2012;105:258–65.
   PubMed Web of Science ®Google Scholar
• Combs SE, Hartmann C, Nikoghosyan A, Jakel O, Karger CP, Haberer T, et al. Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol 2010;95:54–9.
   PubMed Web of Science ®Google Scholar
• Combs SE, Nikoghosyan A, Jaekel O, Karger CP, Haberer T, Munter MW, et al. Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer 2009;115:1348–55.
   PubMed Web of Science ®Google Scholar
• Debus J, Haberer T, Schulz-Ertner D, Jakel O, Wenz F, Enghardt W, et al. [Carbon ion irradiation of skull base tumors at GSI. First clinical results and future perspectives].Strahlenther Onkol 2000;176:211–6.
   PubMed Web of Science ®Google Scholar
• Nikoghosyan AV, Schulz-Ertner D, Herfarth K, Didinger B, Munter MW, Jensen AD, et al. Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer – acute toxicity of 12C for PC. Acta Oncol 2011;50:784–90.
   PubMed Web of Science ®Google Scholar
• Schlampp I, Karger CP, Jakel O, Scholz M, Didinger B, Nikoghosyan A, et al. Temporal lobe reactions after radiotherapy with carbon ions: Incidence and estimation of the relative biological effectiveness by the local effect model. Int J Radiat Oncol Biol Phys 2011;80:815–23.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, Jakel O, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys 2007; 67:171–7.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Didinger B, Debus J. Carbon ion radiation therapy for chordomas and low grade chondrosarcomas – current status of the clinical trials at GSI. Radiother Oncol 2004;73(Suppl 2):S53–6.
   Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 2004;58: 631–40.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, et al. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients. Strahlenther Onkol 2003;179: 598–605.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Jakel O, Haberer T, Kraft G, Scholz M, et al. Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. Int J Radiat Oncol Biol Phys 2003;56:391–8.
   PubMed Web of Science ®Google Scholar
• Debus J, Schulz-Ertner D, Schad L, Essig M, Rhein B, Thillmann CO, et al. Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys 2000;47:591–6.
   PubMed Web of Science ®Google Scholar
• Bugoci DM, Girvigian MR, Chen JC, Miller MM, Rahimian J. Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas. Am J Clin Oncol Epub 2012 Jul 3.
   Google Scholar
• Torres MA, Chang EL, Mahajan A, Lege DG, Riley BA, Zhang X, et al. Optimal treatment planning for skull base chordoma: Photons, protons, or a combination of both?Int J Radiat Oncol Biol Phys 2009;74:1033–9.
   PubMed Web of Science ®Google Scholar
• Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, et al. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: Combined x-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:390–6.
   PubMed Web of Science ®Google Scholar
• Koto M, Hasegawa A, Takagi R, et al. Carbon ion radiotherapy for skull base and paracervical tumors. Proceedings of the NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy, 2011, Center ETOILE, Lyon, NIRS-M-243. 2011. [Abstract].
   Google Scholar
• Kamada T. Overview of the carbon ion therapy at HIMAC (including head and neck tumors, and bone and soft tissue sarcomas). Proceedings of the Joint Symposium 2013 on Carbon Ion Radiotherapy, May 2–3, 2013, Rochester, MN, USA. 2013. [Abstract].
   Google Scholar
• Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, Tsujii H. Carbon ion radiotherapy for skull base chordoma. Skull Base 2009;19:219–24.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jakel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 2007;68:449–57.
   PubMed Web of Science ®Google Scholar
• Nikoghosyan AV, Karapanagiotou-Schenkel I, Munter MW, Jensen AD, Combs SE, Debus J. Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study. BMC Cancer 2010;10:607.
   PubMed Web of Science ®Google Scholar
• Nikoghosyan AV, Rauch G, Munter MW, Jensen AD, Combs SE, Kieser M, et al. Randomised trial of proton vs. carbon ion radiation therapy in patients with low and intermediate grade chondrosarcoma of the skull base, clinical phase III study. BMC Cancer 2010;10:606.
   PubMed Web of Science ®Google Scholar
• Hasegawa A, Mizoe JE, Tsujii H, Kamada T, Jingu K, Iwadate Y, et al. Experience with carbon ion radiotherapy for WHO Grade 2 diffuse astrocytomas. Int J Radiat Oncol Biol Phys 2012;83:100–6.
   PubMed Web of Science ®Google Scholar
• Combs SE, Kieser M, Rieken S, Habermehl D, Jakel O, Haberer T, et al. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA trial. BMC Cancer 2010;10:478.
   PubMed Web of Science ®Google Scholar
• Rieken S, Habermehl D, Haberer T, Jaekel O, Debus J, Combs SE. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): Early treatment results and study concepts. Radiat Oncol 2012;7:41.
   PubMed Web of Science ®Google Scholar
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109.
   PubMed Web of Science ®Google Scholar
• Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: A study of 71 surgical cases. Neurosurg Focus 1997;2:e3.
   Google Scholar
• Lusis E, Gutmann DH. Meningioma: An update. Curr Opin Neurol 2004;17:687–92.
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61:809–16.
   PubMed Web of Science ®Google Scholar
• Simon M, Bostrom J, Koch P, Schramm J. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: Impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 2006;77: 767–73.
   PubMed Web of Science ®Google Scholar
• Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, et al. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol 2006;182:641–6.
   PubMed Web of Science ®Google Scholar
• Hoffmann W, Muhleisen H, Hess CF, Kortmann RD, Schmidt B, Grote EH, et al. Atypical and anaplastic meningiomas – does the new WHO-classification of brain tumours affect the indication for postoperative irradiation?Acta Neurochir (Wien) 1995;135:171–8.
   PubMed Web of Science ®Google Scholar
• Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 1996; 34:817–22.
   PubMed Web of Science ®Google Scholar
• Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: Role of high-dose, 3D- conformal radiation therapy. J Neurooncol 2000;48:151–60.
   PubMed Web of Science ®Google Scholar
• Milker-Zabel S, Zabel A, Schulz-Ertner D, Schlegel W, Wannenmacher M, Debus J. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: Long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005;61:809–16.
   PubMed Web of Science ®Google Scholar
• Smith SJ, Boddu S, Macarthur DC. Atypical meningiomas: WHO moved the goalposts?. Br J Neurosurg 2007;21: 588–92.
   PubMed Web of Science ®Google Scholar
• Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, et al. Atypical and malignant meningioma: Outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys 2008;71:1388–93.
   PubMed Web of Science ®Google Scholar
• Combs SE, Welzel T, Habermehl D, Rieken S, Dittmar JO, Kessel K, et al. Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET. Acta Oncol 2013;52:514–20.
   PubMed Web of Science ®Google Scholar
• Combs SE, Hartmann C, Nikoghosyan A, Jakel O, Karger C, von Deimling A, et al. Carbon ion radiotherapy for high-risk meningiomas. Int J Radiat Oncol Biol Phys 2009;75:399–406.
   PubMedGoogle Scholar
• Combs SE, Edler L, Burkholder I, Rieken S, Habermehl D, Jakel O, et al. Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE trial. BMC Cancer 2010;10:615.
   PubMed Web of Science ®Google Scholar
• Cantu G, Bimbi G, Miceli R, Mariani L, Colombo S, Riccio S, et al. Lymph node metastases in malignant tumors of the paranasal sinuses: Prognostic value and treatment. Arch Otolaryngol Head Neck Surg 2008;134:170–7.
   PubMedGoogle Scholar
• Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 2011;34:76–81.
   PubMed Web of Science ®Google Scholar
• Min R, Siyi L, Wenjun Y, Ow A, Lizheng W, Minjun D, et al. Salivary gland adenoid cystic carcinoma with cervical lymph node metastasis: A preliminary study of 62 cases. Int J Oral Maxillofac Surg 2012;41:952–7.
   PubMed Web of Science ®Google Scholar
• Lodge M, Pijls-Johannesma M, Stirk L, Munro AJ, De Ruysscher D, Jefferson T. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 2007;83:110–22.
   PubMed Web of Science ®Google Scholar
• Pommier P, Liebsch NJ, Deschler DG, Lin DT, McIntyre JF, Barker FG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:1242–9.
   PubMed Web of Science ®Google Scholar
• Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, et al. Radiotherapy for advanced adenoid cystic carcinoma: Neutrons, photons or mixed beam?Radiother Oncol 2001;59:161–7.
   PubMed Web of Science ®Google Scholar
• Schulz-Ertner D, Nikoghosyan A, Didinger B, Munter M, Jakel O, Karger CP, et al. Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques. Cancer 2005;104:338–44.
   PubMed Web of Science ®Google Scholar
• Combs SE, Konkel S, Thilmann C, Debus J, Schulz- Ertner D. Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses. Strahlenther Onkol 2007;183:63–8.
   PubMed Web of Science ®Google Scholar
• Hasegawa A, Koto M, Takagi R, et al. Carbon ion radiotherapy for head and neck tumors. Proceedings of the NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy, 2011, Center ETOILE, Lyon, NIRS-M-243. 2011. [Abstract].
   Google Scholar
• Jingu K, Kishimoto R, Mizoe JE, Hasegawa A, Bessho H, Tsuji H, et al. Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: Prognostic value of pretreatment apparent diffusion coefficient (ADC). Radiother Oncol 2011;98:68–73.
   PubMed Web of Science ®Google Scholar
• Mizoe JE, Hasegawa A, Jingu K, Takagi R, Bessyo H, Morikawa T, et al. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 2012;103:32–7.
   PubMed Web of Science ®Google Scholar
• Mizoe JE, Tsujii H, Kamada T, Matsuoka Y, Tsuji H, Osaka Y, et al. Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004;60:358–64.
   PubMed Web of Science ®Google Scholar
• Yanagi T, Mizoe JE, Hasegawa A, Takagi R, Bessho H, Onda T, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys 2009;74:15–20.
   PubMed Web of Science ®Google Scholar
• Jensen AD, Nikoghosyan AV, Windemuth-Kieselbach C, Debus J, Munter MW. Treatment of malignant sinonasal tumours with intensity-modulated radiotherapy (IMRT) and carbon ion boost (C12). BMC Cancer 2011;11:190.
   PubMed Web of Science ®Google Scholar
• Jensen AD, Krauss J, Potthoff K, Desta A, Habl G, Mavtratzas A, et al. Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx–TPF-C-HIT. BMC Cancer 2011;11:182.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2007;2:916–26.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Baba M, Yamamoto N, Koto M, Sugawara T, Yashiro T, et al. Curative treatment of stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007;67: 750–8.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003;66: 127–40.
   PubMed Web of Science ®Google Scholar
• Nishimura H, Miyamoto T, Yamamoto N, Koto M, Sugimura K, Tsujii H. Radiographic pulmonary and pleural changes after carbon ion irradiation. Int J Radiat Oncol Biol Phys 2003;55:861–6.
   PubMed Web of Science ®Google Scholar
• Okada T, Kamada T, Tsuji H, Mizoe JE, Baba M, Kato S, et al. Carbon ion radiotherapy: Clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res 2010;51:355–64.
   PubMed Web of Science ®Google Scholar
• Sugane T, Baba M, Imai R, Nakajima M, Yamamoto N, Miyamoto T, et al. Carbon ion radiotherapy for elderly patients 80 years and older with stage I non-small cell lung cancer. Lung Cancer 2009;64:45–50.
   PubMed Web of Science ®Google Scholar
• Yamamoto N. Carbon ion radiotherapy in a hypo-fractionate ion regimen for stage I non-small cell lung cancer. Proceedings of the Joint Symposium 2013 on Carbon Ion Radiotherapy, May 2–3, 2013, Rochester, MN, USA. 2013. [Abstract].
   Google Scholar
• Iwata H, Demizu Y, Fujii O, Terashima K, Mima M, Niwa Y, et al. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer. J Thorac Oncol 2013;8:726–35.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Nakajima M, Tsujii H, Kamada T. Carbon ion radiotherapy for oligo-recurrence in the lung. Pulm Med 2013;2013:219746.
   PubMedGoogle Scholar
• Akutsu Y, Yasuda S, Nagata M, Izumi Y, Okazumi S, Shimada H, et al. A phase I/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus. J Surg Oncol 2012;105:750–5.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378–90.
   PubMed Web of Science ®Google Scholar
• Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Sasaki R, et al. Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer 2011;117:4890–904.
   PubMed Web of Science ®Google Scholar
• Ling TC, Kang JI, Bush DA, Slater JD, Yang GY. Proton therapy for hepatocellular carcinoma. Chin J Cancer Res 2012;24:361–7.
   PubMed Web of Science ®Google Scholar
• Murayama S, Fuji H. [Proton beam therapy at Shizuoka Cancer Center]. Gan To Kagaku Ryoho 2009;36: 1806–12.
   PubMedGoogle Scholar
• Kato H, Tsujii H, Miyamoto T, Mizoe JE, Kamada T, Tsuji H, et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis. Int J Radiat Oncol Biol Phys 2004;59: 1468–76.
   PubMed Web of Science ®Google Scholar
• Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Kishimoto R, et al. Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis. Radiother Oncol 2010;96:231–5.
   PubMed Web of Science ®Google Scholar
• Habermehl D, Debus J, Ganten T, Ganten MK, Bauer J, Brecht IC, et al. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma – feasibility and clinical response. Radiat Oncol 2013;8:59.
   PubMed Web of Science ®Google Scholar
• Combs SE, Habermehl D, Ganten T, Schmidt J, Edler L, Burkholder I, et al. Phase I study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial. BMC Cancer 2011;11:67.
   PubMed Web of Science ®Google Scholar
• Quiros RM, Brown KM, Hoffman JP. Neoadjuvant therapy in pancreatic cancer. Cancer Invest 2007;25:267–73.
   PubMed Web of Science ®Google Scholar
• White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001;8:758–65.
   PubMed Web of Science ®Google Scholar
• Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992;127:1335–9.
   PubMed Web of Science ®Google Scholar
• Palmer DH, Stocken DD, Hewitt H, Markham CE, Hassan AB, Johnson PJ, et al. A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007;14:2088–96.
   PubMed Web of Science ®Google Scholar
• Massucco P, Capussotti L, Magnino A, Sperti E, Gatti M, Muratore A, et al. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: Analysis of perioperative outcome and survival. Ann Surg Oncol 2006;13:1201–8.
   PubMed Web of Science ®Google Scholar
• Ammori JB, Colletti LM, Zalupski MM, Eckhauser FE, Greenson JK, Dimick J, et al. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 2003;7:766–72.
   PubMed Web of Science ®Google Scholar
• Hoffman JP, Weese JL, Solin LJ, Engstrom P, Agarwal P, Barber LW, et al. A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg 1995;169:71–7.
   PubMed Web of Science ®Google Scholar
• Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G, et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg 2001;5:121–30.
   PubMed Web of Science ®Google Scholar
• Yamada S, Shinoto M, Imada H, Yasuda S, Kamada T, Tsujii H. Carbon ion radiotherapy for patients with gastrointestinal cancer. PTCOG 49, Chiba, Japan. 2010.
   Google Scholar
• Yamada S. Carbon ion radiotherapy for patients with locally recurrent rectal cancer and pancreas cancer. Proceedings of the Joint Symposium 2013 on Carbon Ion Radiotherapy, May 2–3, 2013, Rochester, MN, USA. 2013. [Abstract].
   Google Scholar
• Yamada S, Shinoto M, Endo S. Carbon ion radiotherapy for patients with locally recurrent rectal cancer. Proceedings of the NIRS-ETOILE 2nd Joint Symposium on Carbon Ion Radiotherapy, 2011, Center ETOILE, Lyon, NIRS-M-243. 2011. [Abstract].
   Google Scholar
• Combs SE, Kieser M, Habermehl D, Weitz J, Jager D, Fossati P, et al. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: The PANDORA-01 trial. BMC Cancer 2012;12:137.
   PubMed Web of Science ®Google Scholar
• Zietman AL. The Titanic and the Iceberg: Prostate proton therapy and health care economics. J Clin Oncol 2007;25:3565–6. [Abstract].
   PubMed Web of Science ®Google Scholar
• Tsuji H. Carbon ion radiotherapy for liver cancer and prostate cancer. Proceedings of the Joint Symposium 2013 on Carbon Iion Radiotherapy, May 2–3, 2013, Rochester, MN, USA. 2013. [Abstract].
   Google Scholar
• Shimazaki J, Tsuji H, Ishikawa H, Kamada T, Harada M, Akakura K, et al. Biochemical failure after carbon ion radiotherapy for prostate cancer. Anticancer Res 2012; 32:3267–73.
   PubMed Web of Science ®Google Scholar
• Jingu K, Tsujii H, Mizoe JE, Hasegawa A, Bessho H, Takagi R, et al. Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. Int J Radiat Oncol Biol Phys 2012;82:2125–31.
   PubMed Web of Science ®Google Scholar
• Sugahara S, Kamada T, Imai R, Tsuji H, Kameda N, Okada T, et al. Carbon ion radiotherapy for localized primary sarcoma of the extremities: Results of a phase I/II trial. Radiother Oncol 2012;105:226–31.
   PubMed Web of Science ®Google Scholar
• Fuchs B, Dickey ID, Yaszemski MJ, Inwards CY, Sim FH. Operative management of sacral chordoma. J Bone Joint Surg Am 2005;87:2211–6.
   PubMed Web of Science ®Google Scholar
• Ciernik IF, Niemierko A, Harmon DC, Kobayashi W, Chen YL, Yock TI, et al. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer 2011;117:4522–30.
   PubMed Web of Science ®Google Scholar
• Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Dean S, Yeap BY, et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009;74:732–9.
   PubMed Web of Science ®Google Scholar
• Blattmann C, Oertel S, Schulz-Ertner D, Rieken S, Haufe S, Ewerbeck V, et al. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer 2010;10:96.
   PubMed Web of Science ®Google Scholar
• Bettega D, Calzolari P, Hessel P, Stucchi CG, Weyrather WK. Neoplastic transformation induced by carbon ions. Int J Radiat Oncol Biol Phys 2009;73:861–8.
   PubMed Web of Science ®Google Scholar
• Hall EJ. The impact of protons on the incidence of second malignancies in radiotherapy. Technol Cancer Res Treat 2007;6:31–4.
   PubMed Web of Science ®Google Scholar
• Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1–7.
   PubMed Web of Science ®Google Scholar
• Combs SE, Kessel KA, Herfarth K, Jensen A, Oertel S, Blattmann C, et al. Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): Establishment of workflow and initial clinical data. Radiat Oncol 2012;7:170.
   PubMed Web of Science ®Google Scholar
• Bert C, Durante M. Motion in radiotherapy: Particle therapy. Phys Med Biol 2011;56:R113–44.
   PubMed Web of Science ®Google Scholar
• Richter D, Schwarzkopf A, Trautmann J, Kramer M, Durante M, Jakel O, et al. Upgrade and benchmarking of a 4D treatment planning system for scanned ion beam therapy. Med Phys 2013;40:051722.
   Google Scholar
• Rietzel E, Bert C. Respiratory motion management in particle therapy. Med Phys 2010;37:449–60.
   PubMed Web of Science ®Google Scholar